News | Interventional Radiology | February 18, 2019

FDA Clears Mirada Medical's Simplicit90y Dosimetry Software

Interventional radiology software helps improve dose calculation and treatment planning for Y90 transarterial radioembolization

FDA Clears Mirada Medical's Simplicit90y Dosimetry Software

February 18, 2019 — Mirada Medical Ltd announced U.S. Food and Drug Administration (FDA) 510(k) clearance for Simplicit90Y. Designed in collaboration with BTG to facilitate personalized treatment for patients with liver cancer, Simplicit90Y is an easy-to-use dosimetry software developed for accelerating dosimetry planning and improving Y90 transarterial radioembolization (TARE) workflow.

Watch the VIDEO: Y90 Embolization of Liver Cancer at Henry Ford Hospital

Simplicit90Y provides digital processing, review and reporting of medical images, including planar scans (static, whole body) and tomographic scans acquired by gamma cameras or positron emission tomography (PET) scanners. The software is intended for use by interventional radiologists or nuclear medicine physicians, with unique options for data display, quality control, image manipulation and quantification analysis. Together, these features allow for more standardized and reproducible dosimetry planning and post-treatment validation, and the ability to personalize the treatment of each patient.

BTG will be at The Society of Interventional Radiology (SIR) 2019 congress, March 23-28 in Austin, Texas.

The FDA 510(k) clearance follows Simplicit90Y’s CE Mark certification and approval for use in Canada.

For more information: www.mirada-medical.com

Related Content

Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Magnetic Resonance Imaging (MRI) | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...
Clinical Trial Explores Opening Blood-Brain Barrier in Fight Against Alzheimer's

Vibhor Krishna, M.D., (right) fits David Shorr with a helmet-like device used in a new clinical trial for Alzheimer’s disease at The Ohio State University Wexner Medical Center. The device uses MRI-guided imaging to deliver focused ultrasound to specific areas of the brain to open the blood-brain barrier. Image courtesy of Ohio State University Wexner Medical Center.

News | Focused Ultrasound Therapy | May 09, 2019
May 9, 2019 — A new clinical trial at The Ohio State University Wexner Medical Center and two other sites is testing
Ultrasonic Device Safe and Effective for Lung Vessel Sealing in Minimally Invasive Lobectomy
News | Interventional Radiology | May 06, 2019
According to a new study, an ultrasonic vessel-sealing device can improve patient outcomes by reducing the incidence of...
360 degree view inside an Interventional radiology lab at Henry Ford Hospital used for neuro-interventions and stroke.
360 Photos | 360 View Photos | May 06, 2019
This is a 360 degree photo view inside the neuro-interventional radiology lab at ...
Multisociety Position Statement Endorses Prostatic Artery Embolization
News | Interventional Radiology | May 02, 2019
A new position statement from interventional radiology professional societies in the U.S. and Europe states that...
A 3-D printed tungsten X-ray system collimator. 3D printed, additive manufacturing for medical imaging.

A 3-D printed tungsten X-ray system collimator. The tungsten alloy powder is printed into the form desired and is laser fused so it can be machined and finished. Previously, making collimators from Tungsten was labor intensive because it required working with sheets of the metal to create the collimator matrix. 

Feature | Medical 3-D Printing | April 29, 2019 | By Steve Jeffery
In ...
Mentice and RAD-AID Collaborate to Improve Access to Interventional Radiology in Resource-constrained Regions
News | Interventional Radiology | April 22, 2019
April 22, 2019 — Mentice AB, provider of endovascular performance solutions, has signed an agreement with the nonprof
Ethicon Launches Global Liver Lesion Ablation Registry
News | Interventional Radiology | April 10, 2019
Johnson & Johnson Medical Devices Companies announced Ethicon has launched a new global registry to collect and...
Qaelum NV and Toyo Corp. Sign Japanese Distribution Agreement for Dose Monitoring Solution
News | Radiation Dose Management | April 10, 2019
Qaelum NV of Leuven, Belgium, and Toyo Corp. of Tokyo, Japan announced they have entered into a cooperation agreement...